Market Opportunity Treat bunion and midfoot correction as a large and growing surgical need, with Treace’s Lapiplasty 3D correction positioned to expand adoption among foot and ankle surgeons when competing solutions may be limited in addressing multi-planar deformities.

Product Expansion Opportunity to cross-sell and upsell ancillary systems such as Adductoplasty, Hammertoe PEEK Fixation, and SpeedPlate into existing customer bases to broaden intraoperative solutions and reduce implant switching.

Clinical Evidence Leverage positive interim clinical data and ongoing trials presented at industry meetings to drive surgeon confidence, payer discussions, and faster adoption, especially for the 3D correction approach that targets root cause of bunions.

Strategic Partnerships Explore partnerships or licensing opportunities with distributors and academic centers, plus competitive intelligence around Zimmer Biomet lawsuits to position Treace as a preferred, litigation-resilient innovator in bunion correction.

Market Presence capitalize on conference appearances and investor outreach (Sidoti Small Cap Conference) to raise brand awareness among KOLs, center-led adoption initiatives, and multi-site orthopedic networks to accelerate market penetration.